PubMed Health⌕ Search

Biomedical subjects

Jerry Eichler

Publications and source records attributed to Jerry Eichler.

22 records · Page 2Linked to original sources

Lipid modification of proteins in Archaea: attachment of a mevalonic acid-based lipid moiety to the surface-layer glycoprotein of Haloferax volcanii follows protein translocation.

Once the newly synthesized surface (S)-layer glycoprotein of the halophilic archaeaon Haloferax volcanii has traversed the plasma membrane, the protein undergoes a membrane-related, Mg(2+)-dependent maturation event, revealed as an increase in the apparent molecular mass and hydrophobicity of the protein. To test whether lipid modification of the S-layer glycoprotein could explain these observations, H. volcanii cells were incubated with a radiolabelled precursor of isoprene, [(3)H]mevalonic acid. In Archaea, isoprenoids serve as the major hydrophobic component of archaeal membrane lipids and have been shown to modify other haloarchaeal S-layer glycoproteins, although little is known of the mechanism, site or purpose of such modification. In the present study we report that the H. volcanii S-layer glycoprotein is modified by a derivative of mevalonic acid and that maturation of the protein was prevented upon treatment with mevinolin (lovastatin), an inhibitor of mevalonic acid biosynthesis. These findings suggest that lipid modification of S-layer glycoproteins is a general property of halophilic archaea and, like S-layer glycoprotein glycosylation, lipid-modification of the S-layer glycoproteins takes place on the external cell surface, i.e. following protein translocation across the membrane.

Acids↗

Protein glycosylation in Haloferax volcanii: partial characterization of a 98-kDa glycoprotein.

The plasma membrane of Haloferax volcanii contains several glycoproteins, including a 98-kDa species. Using lectin-based chromatography, the glycoprotein was isolated and partially characterized. Sequence comparison, based on antibody binding as well as one-dimensional peptide maps show that the 98-kDa glycoprotein is distinct from the S-layer glycoprotein, the major glycoprotein in H. volcanii. The 98-kDa glycoprotein can be further distinguished from the S-layer glycoprotein on the basis of membrane attachment. Unlike the S-layer glycoprotein, the 98-kDa glycoprotein is not associated with the membrane in a Mg2+-dependent manner. Both proteins, however, apparently rely on a similar mechanism of glycosylation, since neither was affected by treatment with bacitracin or tunicamycin, agents known to interfere with protein glycosylation in other species. Finally, the pattern of glycosylation of the 98-kDa glycoprotein is not shared by a 95-kDa glycoprotein of the related Haloferax mediterranei strain.

Anti-Bacterial Agents↗

Getting on target: the archaeal signal recognition particle.

Protein translocation begins with the efficient targeting of secreted and membrane proteins to complexes embedded within the membrane. In Eukarya and Bacteria, this is achieved through the interaction of the signal recognition particle (SRP) with the nascent polypeptide chain. In Archaea, homologs of eukaryal and bacterial SRP-mediated translocation pathway components have been identified. Biochemical analysis has revealed that although the archaeal system incorporates various facets of the eukaryal and bacterial targeting systems, numerous aspects of the archaeal system are unique to this domain of life. Moreover, it is becoming increasingly clear that elucidation of the archaeal SRP pathway will provide answers to basic questions about protein targeting that cannot be obtained from examination of eukaryal or bacterial models. In this review, recent data regarding the molecular composition, functional behavior and evolutionary significance of the archaeal signal recognition particle pathway are discussed.

Archaea↗